A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC

NCT03876925 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
10
Enrollment
INDUSTRY
Sponsor class

Stopped The effect of CT053PTSA in preciously treated patients with advanced and metastatic RCC is not as good as pre-expected

Conditions

Interventions

Sponsor

Sunshine Lake Pharma Co., Ltd.